Lorcaserin
| Lorcaserin | |
|---|---|
| Salts [] | |
|---|---|
| Lorcaserin hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 195.69 g/mol [1] |
| Solubility | Water solubility is greater than 400 mg/mL. [1] |
| Predicted LogP | 2.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H14ClN |
| IUPAC name | (5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
| SMILES | C[C@H]1CNCCC2=C1C=C(C=C2)Cl |
| InChI | InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1 |
| InChIKey | XTTZERNUQAFMOF-QMMMGPOBSA-N |
| CAS number | 616202-92-7 |
| UNII | 637E494O0Z |
| PubChem CID | 11658860 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 11 hours |
| Metabolism | Hepatic (extensive) |
| Excretion | Renal (92.3%), Faecal (2.2%) |
| Routes of administration | Oral |
Lorcaserin (also known as (1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, lorcaserine, LorcaserinA, Adp356, Adp-356, lorcaserinum, A08aa11, (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, (R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine or 1H-3-Benzazepine, 8-chloro-2,3,4,5-tetrahydro-1-methyl-, (1R)-) is a stimulant substance of the phenethylamine class.
Chemistry
Salts []
Stereochemistry []
Lorcaserin is a single defined stereoisomer.
Druglikeness
Lipinski's rule of five
Lorcaserin matches Lipinski's rule of five.Pharmacology
ATC Classification
- alimentary tract and metabolism (A)
- antiobesity preparations, excl. diet products (A08)
- antiobesity preparations, excl. diet products (A08A)
- centrally acting antiobesity products (A08AA)
- lorcaserin (A08AA11)
Mechanism of action []
Although the exact mechanism is unknown, it is believed to involve the selective activation of 5-HT2C receptors in the anorexigenic pro-opiomelanocortin neurons in the arcuate nucleus of the hypothalamus. This results in decreased food intake and satiety by promoting the release of alpha-melanocortin stimulating hormone, which acts on melanocortin-4 receptors. [1]
Medical side effects []
67 side effects listed on drug labels in SIDER 4.1 (lorcaserin).
- Hypoglycaemia
- Headache
- Upper respiratory tract infection
- Nasopharyngitis
- Back pain
- Nausea
- Dizziness
- Urinary tract infection
- Asthenia
- Fatigue
- Diarrhoea
- Cough
- Constipation
- Dry mouth
- Hypertension
- Muscle spasms
- Oedema peripheral
- Vomiting
- Anxiety
- Insomnia
- Oropharyngeal pain
- Gastroenteritis
- Seasonal allergy
- Rhinitis seasonal
- Sinus congestion
- Stress
- Toothache
- Diabetes mellitus
- Cardiac valve disease
- Depression
- Decreased appetite
- Dermatitis
- Rash
- Musculoskeletal pain
- Aortic valve incompetence
- Mental disorder
- Infection
- Confusional state
- Feeling abnormal
- Connective tissue disorder
- Drug abuse
- Eye disorder
- Gastrointestinal disorder
- Cardiac failure congestive
- Hyperhidrosis
- Immune system disorder
- Inflammation
- Mediastinal disorder
- Mitral valve incompetence
- Nervous system disorder
- Tremor
- Angiopathy
- Visual impairment
- Chills
- Malnutrition
- Skin disorder
- Disorientation
- Euphoric mood
- Disturbance in attention
- Mental disability
- Dry eye
- Cognitive disorder
- Vision blurred
- Suicidal ideation
- Serotonin syndrome
- Infestation
- Regurgitation
Indications
- Diabetic
- Obesity
- Type 2 diabetes mellitus
Subjective effects []
Experience reports
Legal status []
- United States: Lorcaserin is a Schedule IV / Withdrawn under the "Controlled Substances Act".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 11658860, Lorcaserin. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/11658860
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lorcaserin. UNII: 637E494O0Z. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/637E494O0Z
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 06:04:37 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 06:04:33 |
| erowid | ok | 2026-11-20 06:04:36 |
| gsrs | ok | 2026-11-20 06:04:34 |
| hmdb | missing (no HMDB id) | 2026-11-20 06:04:33 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 06:04:36 |
| pubchem | ok | 2026-11-20 06:04:33 |
| missing (no r/tripreports posts mention it) | 2026-11-20 06:04:33 | |
| sider | ok | 2026-11-20 06:04:33 |
| structure | ok | 2026-11-20 06:04:33 |
| wikipedia | ok | 2026-11-20 06:04:33 |